Cancer Genomics and Proteomics
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Key Metrics
Journal Specifications
- PublisherINT INST ANTICANCER RESEARCH
- LanguageEnglish
- FrequencyBi-monthly
- LanguageEnglish
- FrequencyBi-monthly
- Publication Start Year2004
- Website URL
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Cancer Genomics and Proteomics been publishing? 
The Cancer Genomics and Proteomics has been publishing since 2004 till date.
How frequently is the Cancer Genomics and Proteomics published?
Cancer Genomics and Proteomics is published Bi-monthly.
Who is the publisher of Cancer Genomics and Proteomics?
The publisher of Cancer Genomics and Proteomics is INT INST ANTICANCER RESEARCH.
How can I view the journal metrics of Cancer Genomics and Proteomics on editage?
For the Cancer Genomics and Proteomics metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Cancer Genomics and Proteomics?
The eISSN number is 1790-6245 and pISSN number is 1109-6535 for Cancer Genomics and Proteomics.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Hepatocellular carcinoma, Genotype, Colorectal cancer, Medulloblastoma, Vector control, Histone deacetylase, Prostate cancer, Extracellular vesicles, Renal carcinoma, Overall survival, Immunohistochemistry, Substrate-level phosphorylation, Gene expression, Breast cancer, Conditioned medium, Senescence, Fusion gene, Betel quid chewing, Xeroderma pigmentosum, Androgen receptor.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.